Pay Transparency + the Power of Preventive Strategies: Episode 3 — Pivoting Toward Preparation in the Life Sciences
Pay Transparency + the Power of Preventive Strategies: Episode 2 — Healthcare Compliance Crossroads
Hospice Insights Podcast - Reimagining How We Navigate Change and Loss: A Conversation with Sonya Dolan and Bridget Sumser of Mettle Health
Podcast - The Fast-Growing Wound Care Industry
Concierge Practices: Getting Started and Staying Compliant
Podcast - J.P. Morgan Healthcare Conference Recap: What Dealmakers Expect in 2026
Illinois Supreme Court Tightens Standing for No-Injury Consumer Claims — The Consumer Finance Podcast
Work This Way: A Labor & Employment Law Podcast | Service Animals, the ADA, and Workplace Rights
Episode 265: Redesigning Clinical Trials Through Technology with Patrick McCarthy of Validcare
From Diligence to Post-Closing: What’s Shifting in 2026 Health Care Transactions
Private Equity Investment in Health Care
Healthcare Trend Report: A Review of the Pharmacy and Drug Supply Chain Sectors
Point-of-Sale Finance Series: Health Care Financing Compliance, Regulatory, and Privacy Pitfalls — Payments Pros – The Payments Law Podcast
Point-of-Sale Finance Series: Health Care Financing Compliance, Regulatory, and Privacy Pitfalls — The Consumer Finance Podcast
AGG Talks: Government Insight for Life Sciences Leaders | Patient Assistance Programs and the False Claims Act: Enforcement Trends and Compliance Risks for Life Sciences Companies
Health-e Law Episode 19: From AI to OBBBA: Healthcare Law Insights from the 2025 WHLC Leadership Summit with Amy Dilcher and Chi Huynh, WHLC Co-Chairs
Video Overview: Healthcare Trend Report - A Review of the Pharmacy and Drug Supply Chain Sectors
Concierge Practices: Understanding the Model and Its Unique Challenges
Beyond the Bylaws: The Medical Staff Show - How to Build Compliant and Effective Peer Review Processes into Your Bylaws, Part 2
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 264: 2026 Healthcare Industry Trends & Challenges with Lauren DeMoss and Matthew Roberts
After four years of unpredictably aggressive—and often controversial—merger review, the expectations were that under the new leadership, the Federal Trade Commission (FTC)’s review of life sciences transactions would return...more
On February 3, 2026, Congress passed and the President signed the Consolidated Appropriations Act, 2026 (“CAA 26”), a legislative package that funds several federal agencies, including the Departments of Labor and Health and...more
On January 28, 2026, Brenna Jenny, Deputy Assistant Attorney General for the Commercial Litigation Branch of the Department of Justice’s Civil Division, delivered comments to False Claims Act (“FCA”) practitioners about DOJ’s...more
In an unpublished memorandum decision, the Ninth Circuit in R.R. v. California Physicians’ Service d/b/a Blue Shield of California, affirmed the insurer and administrator’s denial of benefits for a dependent’s residential...more
Trending in Telehealth highlights monthly state legislative and regulatory developments that impact healthcare providers, telehealth and digital health companies, pharmacists, and technology companies that deliver and...more
At some point, maybe it’s just simple math. What does it cost to not get in trouble with the HHS Office for Civil Rights (OCR)? This is not about dropping thousands of dollars to do a security risk analysis—and don’t forget...more
On February 3, 2026, President Trump signed H.R.7148, the Consolidated Appropriations Act, 2026, into law. Section 6703 of the Act, “Increasing Transparency in Generic Drug Applications,” amends the Federal Food, Drug, and...more
As the frozen precipitation is continuing to thaw across the upper part of Mississippi, the Mississippi legislature continues to forge ahead in this year’s legislative session....more
On February 3, 2026, a comprehensive fiscal year (FY) 2026 appropriations package advanced through the US House of Representatives, finishing the legislative process for five of the six remaining appropriations bills....more
On January 27, 2026, the Department of Health and Human Services, Office of Inspector General (“OIG”) published a Special Advisory Bulletin (the “SAB”) addressing key considerations for pharmaceutical manufacturers' offering...more
As a follow-up to our post earlier this week, President Trump has signed into law the Consolidated Appropriations Act, 2026 (CAA). The law extends key COVID-19 era Medicare telehealth flexibilities through December 31, 2027...more
In advance of the anticipated rollout of the “TrumpRx” website, a platform promising lower-priced drugs sold directly to consumers, the Office of Inspector General of the Department of Health and Human Services (OIG) released...more
A coalition of 48 AGs led by Connecticut AG William Tong reached separate settlements with Lannett Company, Inc. (“Lannett”) and Bausch Health US, LLC/Bausch Health Americas, Inc. (“Bausch”) in generic-drug antitrust...more
Recent congressional activity reflects a dual-track approach to hemp regulation: lawmakers are simultaneously seeking to delay the implementation of certain existing hemp provisions while advancing legislation that would...more
On January 22, 2026, the Department of Justice (DOJ or the Department) Criminal Fraud Section issued its 2025 Year in Review summary (YIR Summary). Our more detailed analysis of the full YIR Summary can be found here. DOJ’s...more
The Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), has issued two landmark proposed rules that would significantly restrict the delivery and funding of...more
On January 26, the Centers for Medicare & Medicaid Services (CMS) released the Calendar Year 2027 Advance Notice of Methodological Changes for Medicare Advantage (MA) capitation rates and Medicare Part D payment policies. CMS...more
Iowa AG Brenna Bird filed a lawsuit against multiple pharmacy benefit managers (PBMs) and insulin manufacturers, alleging the companies violated Iowa’s Consumer Fraud Act by artificially inflating diabetes drug prices for...more
On Feb. 3, 2026, President Trump signed into law the Consolidated Budget Act of 2026. One small but mighty provision included in the Act will create a compliance burden on hospitals that provide outpatient off-campus...more
Don’t miss game-changing compliance education, connections, and program solutions in Orlando - For three decades, the Compliance Institute® (CI) has been the ultimate go-to event for healthcare compliance professionals...more
Congress enacted the fiscal year 2026 Labor, Health and Human Services, Education, and Related Agencies (LHHS) appropriations bill, providing roughly $221 billion in total funding across the subcommittee’s jurisdiction,...more
As the telehealth industry is acutely aware, Medicare’s telehealth flexibilities and the Acute Hospital Care at Home Program, both of which have been in place since 2020, expired on January 31, 2026. While on that day the...more
Medicare reimbursement for off-campus hospital outpatient departments is once again under attack....more
The US Food and Drug Administration (FDA) has approved a Phase 1 clinical trial from Life Biosciences that aims to help certain eye cells act younger and improve vision in glaucoma and related conditions....more
On Thursday, January 22, 2026, the U.S. Government Accountability Office (GAO) released a report containing three main recommendations for improving the oversight and operations of the Organ Procurement Transplant Network...more